share_log

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hege Kristen

SEC ·  Jul 2, 2024 05:05
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more